The 72-Hour Treatment Gap: Why Continuity of Care is Critical to Preventing Overdose in 2026

In the landscape of public safety and addiction medicine in 2026, we have reached a pivotal crossroads. Over the last decade, the primary hurdle in addressing the opioid crisis was defined as a lack of “access.” Policy changes, the removal of the X-waiver, and the rapid expansion of telehealth for Medication-Assisted Treatment (MAT) have largely addressed this initial barrier. Today, a patient in a high-risk environment—whether they are transitioning out of a correctional facility in Miami-Dade or navigating the streets of Los Angeles—can often secure a buprenorphine prescription within hours.

However, from my perspective as a veteran in law enforcement with a background in Public Administration (MPA), I have observed a second, more insidious challenge: the continuity of care. Access to a script is a starting point, not a finish line. The real systemic vulnerability today is what I call the 72-hour treatment gap. This is the window where administrative friction, pharmacy logistics, or care transitions lead to an interruption in medication. In this brief period, the biological protection afforded by MAT vanishes, and the risk of a fatal overdose spikes. To solve the 2026 overdose crisis, our focus must shift from simply initiating treatment to the operational excellence required to maintain it.

1. Introduction: The Real Risk is Not Access Alone

From a public systems perspective, we have moved from a “scarcity model” to an “execution model.” We have the tools, the medication, and the digital infrastructure to reach almost anyone. Yet, the overdose rates in high-impact regions continue to fluctuate.

The breakdown rarely occurs because a patient doesn’t want help. Instead, patients are frequently lost during the “hand-offs”—the transitions between jail and the community, between one insurance provider and another, or even between the doctor’s office and the pharmacy counter.

When a patient is stabilized on buprenorphine, they are medically shielded. When that shield is removed for even 48 to 72 hours, they enter a zone of extreme physiological and psychological risk. Access alone cannot solve this; only a dedicated focus on telehealth continuity of care opioid treatment can.

2. Why Continuity Matters: The Physiology of the Gap

To understand why a 72-hour interruption is so dangerous, we must look at both the clinical data and the street-level reality of opioid tolerance.

Loss of Opioid Tolerance

When a patient faces an overdose risk after MAT interruption, it is often because they attempt to bridge the gap with illicit substances. Because their tolerance has dropped significantly in just a few days, the dose of fentanyl they previously used may now be lethal. This is the biological reality of the treatment gap and a reality I have personally seen. 

The Post-Incarceration Vulnerability

One of the most critical transitions occurs during re-entry. Data consistently shows that individuals are 13 to 40 times more likely to die of an overdose in the first two weeks following release from a correctional facility compared to the general population. This is a staggering post incarceration overdose risk that is almost entirely driven by the lack of a seamless hand-off to community-based care. If a released individual cannot fill their prescription within the first 72 hours, the likelihood of a return to illicit use—and a subsequent fatal overdose—increases exponentially.

3. Where Breakdowns Happen: Identifying Systemic Friction Points

Continuity gaps are rarely the result of a single person’s failure. They are usually the result of “friction” within the healthcare and pharmaceutical infrastructure. Identifying these points is the first step in building a better system.

Suboxone Pharmacy Issues

Even with a valid prescription, many patients encounter Suboxone pharmacy issues that create immediate delays:

• Stock Availability: Pharmacies in high-risk areas may have limited stock of specific buprenorphine formulations or strengths.
• Dispensing Thresholds: Regulatory caps can sometimes limit how much a pharmacy can dispense in a given month.
• Operational Hours: If a script is sent on a Friday afternoon but requires a clarification call, a patient may be left without medication until Monday morning.

Insurance and Prior Authorization (PA)

The administrative burden of Prior Authorization remains a significant hurdle. When an insurance provider flags a MAT prescription for review, it can trigger a delay of several days. For a patient in early recovery, a 72-hour wait for an insurance company to “approve” their life-saving medication is an unacceptable clinical risk.

Communication Gaps

Fragmented care is often silent care. If a pharmacist cannot reach a provider to resolve a minor dosage question, the script sits unfilled. In high-volume, low-touch telehealth models, this lack of real-time responsiveness is a primary driver of treatment interruptions.

4. The Role of Supportive Care Models

The solution to the 72-hour gap is not simply “more apps.” or prescribing platforms that don’t have structured continuity models, it is the implementation of higher-support care environments that prioritize MAT retention strategies. These models are characterized by their ability to anticipate and solve barriers in real time.

Characteristics of High-Support Care:

• Responsive Communication: Clinicians and support staff who are reachable when a pharmacy issue arises, not just during scheduled appointments.
• Active Pharmacy Navigation: Instead of just sending a script, the team actively engages and coordinates with the pharmacist to ensure the patient can actually pick up the medication.
• Insurance Advocacy: A team that understands how to expedite Prior Authorizations or identifies bridge-funding solutions to prevent gaps.
• Proactive Follow-Up: infrastructure to handle pharmacy issues to ensure patients successfully obtained their medication within 24 hours of the prescription being sent.

Organizations like DevotedDOc align with this model by treating the “logistics of care” with the same importance as the “clinical diagnosis.” They recognize that a doctor’s job isn’t done until the medication is in the patient’s hands.

5. Public Safety & Policy Perspective: The MPA Lens

From the perspective of an MPA, continuity of care is a matter of municipal efficiency and public safety. When treatment systems fail, the burden is shifted to other public resources.

Impact on Emergency Systems

Every treatment gap that leads to a relapse potentially results in an emergency department (ED) visit or an EMS dispatch. These are high-cost interventions that could have been prevented by a $100 medication-continuity strategy.

MAT and Recidivism

There is a clear policy tie-in between MAT and recidivism reduction. Stable, medicated individuals are significantly less likely to engage in the “survival crimes” often associated with untreated opioid use disorder. When we ensure that an individual leaving jail has an immediate, 72-hour bridge to community MAT, we are directly investing in lower crime rates and higher community stability.

6. Miami-Dade County Focus: Addressing the South Florida Crisis

Miami-Dade County represents a unique challenge in the 2026 opioid landscape. With a large, transient population and one of the nation’s busiest correctional release cycles, the “treatment gap” here is particularly wide.

Miami-Dade Opioid Trends

Recent Miami-Dade opioid crisis data indicates that while initial MAT enrollments are up, the “retention at 90 days” remains a challenge. The overlap of OUD with high rates of HIV and Hepatitis C in South Florida adds another layer of complexity.

• Integrated Care: In Miami-Dade, continuity must include not only MAT but also infectious disease monitoring.
• Local Resources: Programs like the Miami-Dade HIV/AIDS initiatives and county-level behavioral health task forces are moving toward more integrated, “one-stop” models to prevent patients from falling through the cracks of a fragmented system.

7. California & Los Angeles: Scaling the Solution

The challenges in California—specifically within the Los Angeles County system—are similar in nature but massive in scale.

Los Angeles Opioid Overdose Data

Los Angeles continues to face significant fentanyl-related mortality. The sheer size of the Medi-Cal population means that any interruption in state-level funding or a shift in provider networks can lead to thousands of patients facing a treatment gap simultaneously.

• CalAIM Integration: California’s CalAIM initiative is a bold step toward integrating social services with healthcare. However, the operational reality on the ground still requires telehealth continuity of care opioid treatment providers who can navigate the specific “Managed Care” hurdles of the California system.
• California MAT Programs: The success of California’s response depends on translating these high-level policies into “same-day” outcomes for patients in places like Skid Row or the Inland Empire.

8. Clinical Commentary: Building the Infrastructure of Recovery

By Dr. Matthew Berrios, Founder of DevotedDOC

My background in Emergency Medicine (EM) serves as the direct blueprint for how we built DevotedDOc. In the ERs of Miami, Tampa, and Orlando, I spent years treating the “end stage” of a failed treatment hand-off. I saw patients who were medically stabilized on buprenorphine, only to have their recovery derailed by a 72-hour pharmacy delay or an administrative insurance barrier.

At DevotedDOc, we’ve pivoted from merely “treating” addiction to providing the high-support infrastructure necessary to prevent these systemic collapses. My EM training taught me that in a crisis, seconds matter—in addiction, 48 to 72 hours is the difference between a successful recovery and a fatal overdose.

The Strategic Value of Emergency Room Avoidance

From a public safety perspective, the most expensive place to treat Opioid Use Disorder (OUD) is the Emergency Department. When a patient in Jacksonville or Miami-Dade loses access to their medication, they don’t just disappear—they resurface in our overcrowded EDs, placing an immense burden on municipal budgets and hospital resources.

By focusing on same-day buprenorphine access in Florida, DevotedDOC operates as a preventative infrastructure. We prioritize:

• Active Pharmacy Advocacy: We don’t just send a script; our team navigates the specific stock and insurance hurdles unique to the Florida opioid crisis landscape.
• Stabilization: We recognize that even a 24-hour gap destabilizes a patient’s neurobiology. Our workflow is designed to maintain a “pharmacological shield,” effectively ensuring ER avoidance by keeping the patient out of withdrawal and away from high-potency illicit fentanyl.

In South Florida and across the state’s urban centers, we are moving past the “traditional clinic” model. We are building a high-reliability organization that treats continuity as a clinical vital sign. At DevotedDOC, we don’t just hope the system works for the patient; we build the system that makes failure impossible.

9. Conclusion: Continuity as the Next Phase of Telemedicine

The first phase of the telemedicine revolution was about Access. We have succeeded in making it possible for someone to see a doctor from their living room.

The second phase, which we must master in 2026, is about Continuity.

The success of our public health response to the opioid crisis will not be measured by how many prescriptions we write, but by how many patients we keep in treatment through the inevitable friction of real-world care. This requires coordination, operational follow-through, and a refusal to accept “administrative delays” as a valid reason for a patient to risk an overdose.

When we bridge the 72-hour treatment gap, we aren’t just filling a script; we are preserving a life.

Frequently Asked Questions

References & Public Health Resources

• Centers for Disease Control and Prevention (CDC): Overdose Prevention and Data
• Miami-Dade County Health Department: Behavioral Health and HIV Services
• California Department of Public Health: Overdose Surveillance Dashboard
• Los Angeles County Public Health: Substance Abuse Prevention and Control (SAPC)
• National Institute on Drug Abuse (NIDA): Research on MAT and Criminal Justice Outcomes
• CalAIM (California Advancing and Innovating Medi-Cal): Official Policy Initiatives